Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Yeda Research & Development patents polypeptides comprising propeptides of human lysyl oxidase

Nov. 19, 2020

PTC Therapeutics initiates phase I study of PTC-518

Nov. 19, 2020

Vimpat CV approved in U.S. for PGTCS, pediatric use for Vimpat injection expanded

Nov. 18, 2020

FDA issues complete response letter related to ALKS-3831 manufacturing records review

Nov. 18, 2020

Topline phase III data reported for NurOwn in ALS

Nov. 18, 2020

Lundbeck identifies new Kv3.1 potassium channel activators

Nov. 17, 2020

Cerevance presents phase Ib data on CVN-058 for schizophrenia cognition

Nov. 17, 2020

Inhibition of the BDNF-TrkB pathway shows pain recession effect in a rat model

Nov. 16, 2020

New phase I study evaluates EDG-5506 for Becker muscular dystrophy

Nov. 12, 2020

Small molecule targets same repeat expansion in distinct diseases

Nov. 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...